About D3 Medicine
D3 Medicine is a company based in Parsippany Troy Hills (United States) founded in 2012 was acquired by Certara in September 2016.. D3 Medicine offers products and services including Phoenix™, Pinnacle 21, and Simcyp™. D3 Medicine operates in a competitive market with competitors including Indegene, Clinigen, IntegriChain, Zuellig Pharma and Fishawack, among others.
- Headquarter Parsippany Troy Hills, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of D3 Medicine
D3 Medicine offers a comprehensive portfolio of products and services, including Phoenix™, Pinnacle 21, and Simcyp™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tool for PK, PD, and toxicokinetic analysis in drug development.
Platform for data standardization and validation in clinical trials.
System for predicting drug behavior in various populations.
Funding Insights of D3 Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in D3 Medicine
D3 Medicine has secured backing from 1 investor. Prominent investors backing the company include Certara. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of a platform for in silico drug discovery and consulting services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by D3 Medicine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - D3 Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
D3 Medicine Comparisons
Competitors of D3 Medicine
D3 Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Clinigen, IntegriChain, Zuellig Pharma and Fishawack, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Suite solutions are provided for payers and healthcare providers.
|
|
| domain | founded_year | HQ Location |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| domain | founded_year | HQ Location |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| domain | founded_year | HQ Location |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| domain | founded_year | HQ Location |
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
|
|
| domain | founded_year | HQ Location |
Precision medicine integration is facilitated through analytics and services.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about D3 Medicine
When was D3 Medicine founded?
D3 Medicine was founded in 2012.
Where is D3 Medicine located?
D3 Medicine is headquartered in Parsippany Troy Hills, United States. It is registered at Parsippany Troy Hills, New Jersey, United States.
What does D3 Medicine do?
D3 Medicine was founded in 2012 and is based in Parsippany Troy Hills, United States. As a Certara company, global solutions for drug development, due diligence, and business development are offered. Clinical pharmacology and translational medicine strategies are specialized in to support progression from preclinical stages to proof-of-concept and to advance clinical phases. Expertise in PKPD studies is held by consultants who have contributed to peer-reviewed journals.
Who are the top competitors of D3 Medicine?
D3 Medicine's top competitors include Indegene, Zuellig Pharma and IntegriChain.
What products or services does D3 Medicine offer?
D3 Medicine offers Phoenix™, Pinnacle 21, and Simcyp™.
Who are D3 Medicine's investors?
D3 Medicine has 1 investor. Key investors include Certara.